Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary W Williams

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Pain and Headache Reports|November 12, 2005
An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitorsGary W Williams
Briefings in Bioinformatics|July 26, 2002
BLAST and go?Lisa J Mullan, Gary W Williams
Bioinformatics (Oxford, England)|April 3, 2004
Pelican: pedigree editor for linkage computer analysisFrank Dudbridge, Tim Carver, Gary W Williams
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 29, 2005
Ocular hypotensive DP-class prostaglandin receptor affinities determined by quantitative autoradiography on human eye sectionsNajam A Sharif, Terry L Davis, Gary W Williams
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptorsCurtis R Kelly, Gary W Williams, Najam A Sharif
Arthritis and Rheumatism|November 13, 2003
Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trialAllan Gibofsky, Gary W Williams, Frank McKenna, et al.
The Journal of Pharmacy and Pharmacology|October 16, 2004
Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulationNajam A Sharif, Colene D Drace, Gary W Williams, et al.
Clinical Therapeutics|May 9, 2006
A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptomsGary W Williams, Alan J Kivitz, Mark T Brown, et al.
The American Journal of Cardiology|October 22, 2008
The editor's roundtable: nonsteroidal antiinflammatory drugs and cardiovascular riskVincent E Friedewald, Joel S Bennett, Milton Packer, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 3, 2005
Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyesNaj A Sharif, Gary W Williams, Julie Y Crider, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Pain and Headache Reports|November 12, 2005
An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitorsGary W Williams
Briefings in Bioinformatics|July 26, 2002
BLAST and go?Lisa J Mullan, Gary W Williams
Bioinformatics (Oxford, England)|April 3, 2004
Pelican: pedigree editor for linkage computer analysisFrank Dudbridge, Tim Carver, Gary W Williams
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 29, 2005
Ocular hypotensive DP-class prostaglandin receptor affinities determined by quantitative autoradiography on human eye sectionsNajam A Sharif, Terry L Davis, Gary W Williams
The Journal of Pharmacology and Experimental Therapeutics|December 20, 2002
Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptorsCurtis R Kelly, Gary W Williams, Najam A Sharif
Arthritis and Rheumatism|November 13, 2003
Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trialAllan Gibofsky, Gary W Williams, Frank McKenna, et al.
The Journal of Pharmacy and Pharmacology|October 16, 2004
Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulationNajam A Sharif, Colene D Drace, Gary W Williams, et al.
Clinical Therapeutics|May 9, 2006
A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptomsGary W Williams, Alan J Kivitz, Mark T Brown, et al.
The American Journal of Cardiology|October 22, 2008
The editor's roundtable: nonsteroidal antiinflammatory drugs and cardiovascular riskVincent E Friedewald, Joel S Bennett, Milton Packer, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 3, 2005
Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyesNaj A Sharif, Gary W Williams, Julie Y Crider, et al.
Pageof 3